Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic Cancer
Clinical trial NCT06572813 · RECRUITING
Trial details
- NCT number
- NCT06572813
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-15
- Primary completion
- 2026-09-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.